healthcare
-
Metrodora promised comprehensive treatment. But within two years, it abruptly closed.
The clinic sought to cure “neuroimmune disorders” like Long COVID and myalgic encephalomyelitis. Former patients feel betrayed.
-
The CDC just sidelined these childhood vaccines. Here’s what they prevent.
The federal government has drastically scaled back the number of recommended childhood immunizations, sidelining six routine vaccines that have safeguarded millions from serious diseases, long-term disability, and death.
-
New AI tools are helping some people manage Long COVID
RTHM and TurnTo recently debuted Long COVID intelligence platforms. Some have found them helpful, but others are concerned about AI.
-
Telehealth is vital for people with Long COVID. Don’t let it disappear.
Changes to telehealth policies are more than an inconvenience. For many of us, critical infrastructure is in jeopardy, and we urgently need government policy to protect it.
-
Despite Long COVID’s ongoing impact, research in Colombia is limited
One of the few Long COVID research studies in Colombia is testing cognitive rehabilitation therapy. This approach recently failed in a U.S. clinical trial.
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
This fall, an international group of people known as Team Nevra has led an ongoing campaign to fundraise and help find care for Nevra Elis, an advocate living with severe myalgic encephalomyelitis (ME).
-
International Long COVID conference spotlights biomarker and mechanism research
The event, now in its third year, also revealed updates about clinical trials and healthcare for the disease.
-
Less than 20% of Long COVID trials involving exercise even mention post-exertional malaise
An analysis by The Sick Times find that less than 15% of Long COVID clinical trials testing the benefits of exercise or cardiopulmonary rehabilitation measured post-exertional malaise, according to their trial registration, while a handful excluded participants who experience it.
-
Business school competition centers Long COVID and IACCs
At this case competition in Ann Arbor, Michigan, the winning team sought to better connect people with IACCs and healthcare providers who serve them.
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
Recent studies add evidence to a prior phase 3 clinical trial, suggesting that taking the diabetes drug during acute COVID-19 reduces the risk of long-term symptoms.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
These artists are making concerts safer with COVID-19 precautions
-
Sophia Yau-Weeks’ new single, “Nobody’s Laughing,” grapples with the isolation of Long COVID
-
Research updates, February 17
-
National COVID-19 trends, February 17
-
“Invisible Illness” could have been transgressive. Instead, it minimizes Long COVID.
Tags
advocacy arts CDC clinical trials COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health Q&A research update science Trump administration updates and events vaccines wastewater surveillance